Bosutinib is a safe oral medicine with good bioavailability. It is effective for treating chronic myeloid leukemia (CML).
[1] It is also a potent ATP-competitive inhibitor for Src tyrosine kinase. Bosutinib inhibits epidermal growth factor receptor (EGFR). It suppresses solid tumors associated with breast, pancreas and prostate.
[2]